Takeda Pharmaceutical Company Limited
Market Cap
$58.10B
P/E Ratio
83.59
EPS
$0.22
Dividend Yield
3.39%
52-Week Range
$12.99 — $18.82
Volume
2.75M
Avg Volume
2.91M
Beta
0.10
P/E (TTM)
83.59
Forward P/E
0.34
PEG Ratio
0.35
P/S (TTM)
2.06
P/B (TTM)
1.21
P/FCF
24.87
EV/EBITDA
26.41x
EV/Sales
—
ROE (TTM)
0.02%
ROA (TTM)
0.01%
ROIC
0.01%
Gross Margin
0.59%
Operating Margin
0.10%
Net Margin
0.09%
Debt/Equity
0.64
Current Ratio
1.19
EPS Growth (YoY)
+3.37%
Revenue Growth (YoY)
+0.05%
EPS Growth (3Y)
-0.14%
EPS Growth (5Y)
+1.33%
Sales Growth (3Y)
+0.09%
Sales Growth (5Y)
+0.07%
EPS Est (This Year)
$54.41
EPS Est (Next Year)
$95.51
Dividend Yield
—
Annual Dividend
$0.32
Payout Ratio
1.44%
Frequency
—
Ex-Dividend Date
2025-09-30
Cash/Share
$482.36
Buy
1 = Strong Buy, 5 = Strong Sell
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
3.16B
Float
3.16B
Free Float %
99.93%
RSI (14)
80.00
SMA 20
$16.91
SMA 50
$15.80
SMA 200
$14.95
ATR (14)
0.31
Volatility (Week)
0.01%
Volatility (Month)
0.01%
Pattern
—
1 Day
+2.09%
1 Week
+3.84%
1 Month
+10.97%
3 Months
+32.50%
6 Months
+25.43%
1 Year
—
YTD
+15.88%
All-Time High
$18.16
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
JP
Exchange
NYSE
IPO Date
2010-01-05
Employees
49281
CEO
Christophe Weber
Index Membership
—
Website
https://www.takeda.com
Takeda Pharmaceutical Company Limited (TAK) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NYSE. With a market capitalization of $58.10B, a P/E ratio of 83.59, and a dividend yield of 3.39%, TAK is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare TAK against other stocks using dozens of fundamental and technical filters.
Takeda Pharmaceutical Company Limited (TAK) has a trailing twelve-month (TTM) P/E ratio of 83.59. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Takeda Pharmaceutical Company Limited (TAK) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Takeda Pharmaceutical Company Limited (TAK) has a market capitalization of $58.10 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Takeda Pharmaceutical Company Limited (TAK) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell).
Takeda Pharmaceutical Company Limited (TAK) has returned +15.88% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.